|
ABUS
|
Arbutus Biopharma Corporation
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
AGLE
|
Aeglea BioTherapeutics, Inc.
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
US
|
NASDAQ
|
|
AXLA
|
Axcella Health Inc.
|
US
|
NASDAQ
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
US
|
NYSE
|
|
GLMD
|
Galmed Pharmaceuticals Ltd.
|
US
|
NASDAQ
|
|
IMUX
|
Immunic, Inc.
|
US
|
NASDAQ
|
|
LPCN
|
Lipocine Inc.
|
US
|
NASDAQ
|
|
NHTC
|
Natural Health Trends Corp.
|
US
|
NASDAQ
|
|
NTLA
|
Intellia Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NVS
|
Novartis AG
|
US
|
NYSE
|
|
ONTX
|
Onconova Therapeutics, Inc.
|
US
|
NASDAQ
|
|
SYBX
|
Synlogic, Inc.
|
US
|
NASDAQ
|
|
VTGN
|
VistaGen Therapeutics, Inc.
|
US
|
NASDAQ
|
|
YTEN
|
Yield10 Bioscience, Inc
|
US
|
NASDAQ
|
|
AQSZF
|
Aequus Pharmaceuticals Inc
|
US
|
OTC
|
|
CAPS
|
Capstone Therapeutics Corp
|
US
|
OTC
|
|
DNPUF
|
Sumitomo Dainippon Pharma Co Ltd
|
US
|
OTC
|